Table 3. Summary of medications pertinent to coated-platelet levels, use of anticoagulation, antiplatelet therapy, and surgical/endovascular treatments at the time of discharge for all patients according to coated-platelet tertiles.
| Treatment at the time of discharge |
Coated-platelet level (%) |
P value | ||
|---|---|---|---|---|
| Lowest tertile (n=60) | Middle tertile (n=60) | Upper tertile (n=60) | ||
| Statin use | 45 (75%) | 47 (78%) | 43 (72%) | 0.70 |
| Antiplatelet use | 54 (90%) | 55 (92%) | 54 (90%) | 0.94 |
| Aspirin | 25 (42%) | 26 (43%) | 25 (42%) | 0.98 |
| Clopidogrel | 20 (33%) | 21 (35%) | 22 (37%) | 0.93 |
| Combination aspirin/extended-release dipyridamole | 9 (15%) | 8 (13%) | 7 (12%) | 0.87 |
| Anticoagulation use | 12 (20%) | 13 (22%) | 13 (22%) | 0.97 |
| Concomitant antiplatelet and anticoagulation use | 7 (12%) | 9 (15%) | 8 (13%) | 0.87 |
| SSRI use | 4 (7%) | 4 (7%) | 5 (8%) | 0.90 |
| Surgical/endovascular procedures | 7 (12%) | 5 (8%) | 9 (15%) | 0.52 |
SSRI, selective serotonin reuptake inhibitors.